[Bisoprolol: opportunities in the treatment of hypertension]

Kardiologiia. 2012;52(6):80-5.
[Article in Russian]


Bisoprolol (bisoprolol fumarate) - -cardioselective blocker, does not possess intrinsic sympathomimetic and membrane stabilizing activity. The main indications for bisoprolol are arterial hypertension (AH) and heart failure. This article provides an overview of the literature on the potential uses of bisoprolol in the treatment of hypertension. The features of the pharmacokinetics of the drug. The data on the effectiveness of bisoprolol in hypertension and tolerability in patients with concomitant disorders: diabetes, chronic obstructive pulmonary disease, peripheral atherosclerosis. Proofs of the high efficiency of antianginal bisoprola and justified the use of the drug in patients with hypertension and coronary heart disease. The capabilities of bisoprolol in the perioperative correction of hypertension. The data and pharmacoeconomic properties of bisoprolol generic counterparts.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / administration & dosage
  • Adrenergic beta-1 Receptor Antagonists / adverse effects
  • Adrenergic beta-1 Receptor Antagonists / pharmacokinetics
  • Biological Availability
  • Bisoprolol* / administration & dosage
  • Bisoprolol* / adverse effects
  • Bisoprolol* / pharmacokinetics
  • Comorbidity
  • Coronary Disease* / complications
  • Coronary Disease* / drug therapy
  • Coronary Disease* / physiopathology
  • Drugs, Generic* / economics
  • Drugs, Generic* / pharmacokinetics
  • Heart Failure* / complications
  • Heart Failure* / drug therapy
  • Heart Failure* / physiopathology
  • Humans
  • Hypertension* / complications
  • Hypertension* / drug therapy
  • Hypertension* / physiopathology
  • Perioperative Care / methods
  • Therapeutic Equivalency
  • Treatment Outcome


  • Adrenergic beta-1 Receptor Antagonists
  • Drugs, Generic
  • Bisoprolol